Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HACD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NCKIPSD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAG11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PET117 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF770 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRGM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF252P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CPM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C21orf62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OFCC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAPTM4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929480 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NES - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SULT2A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on